Results 191 to 200 of about 669,979 (252)

Circulating biomarkers in patients with progressive fibrosing interstitial lung disease treated with nintedanib: a pilot study. [PDF]

Sci Rep
Miceli V, Callari A, Calzolari E, Castelbuono S, Claudia C, Lanzarone N, Martino L, Conaldi PG, Pinzani M, Vitulo P.   +9 more
europepmc   +1 more source

Global, regional, and national burden of interstitial lung diseases and pulmonary sarcoidosis from 2000 to 2021: a systematic analysis of incidence, mortality, and disability-adjusted life years. [PDF]

Front Public Health
Zhou M, Zhou Y, Yang X, Zhou K, Zhu X.
europepmc   +1 more source

Longitudinal changes in KL6 levels predict acute exacerbation in fibrotic interstitial lung disease. [PDF]

Sci Rep
Shiroshita A, Anan K, Shirakawa C, Shiba H, Yajima N.   +4 more
europepmc   +1 more source

A potential new entity pending further validation of pulmonary primary interstitial Tumor: Lymphangioleiomyomatosis-like. [PDF]

Respir Med Case Rep
Zhao L, Shen X, Niu Y, Chen H, Zhong D.
europepmc   +1 more source

Telomere Shortening in Interstitial Lung Disease: Challenges and Promises. [PDF]

Clin Respir J
Jin H, Song J, Gao R, Sha B, Wang S, Luo P, Yu L, Xu X, Wang X.   +8 more
europepmc   +1 more source

The Role of Monocytes in the Natural History of Idiopathic Pulmonary Fibrosis: A Systematic Literature Review. [PDF]

Int J Mol Sci
Lema D, Kosak Lopez E, Lam J, Tskhakaia I, Gonzalez Moret Y, Abdollahi S.   +5 more
europepmc   +1 more source